Back to search

University of British Columbia

Optimization of lipid nanoparticles containing small molecule drugs and genetic drugs

Abstract

dc:description

Lipid-based nanoparticle (LNP) drug delivery vehicles can be used for in vivo delivery of a variety of bioactive molecules including nucleic acid polymers and small molecule drugs for applications ranging from improving the efficacy of anticancer drugs to enabling gene therapies. While liposomal systems containing small molecule drugs can be designed to be relatively nontoxic and long circulating, the ability to trigger rapid release of drug cargo at the target site remains elusive, severely limiting their therapeutic index. The first objective of this thesis is to develop lipid nanoparticles that can release a larger payload at the target site to improve their overall efficacy. Despite more than 30 years of experimentation, triggered release systems for liposomes containing anticancer drugs that leak contents in response to local heating or irradiation have failed to result in clinically approved applications. Chapters 3 and 4 of this thesis focus on incorporating photoswitchable lipids or metal nanoparticles into previously well-established liposomes, making them responsive to externally applied radiation such as laser light to trigger drug release. These novel liposomal systems have similar size and drug encapsulation properties as parent systems, while also exhibiting triggered release properties. Additionally, systems currently being used for delivery of genetic drugs such as RNAbased drugs only result in effective gene silencing or gene expression in the liver. The second objective of this thesis is to develop transfection competent long circulating systems that can transfect extra-hepatic tissues following intravenous administration. Chapter 5 of this dissertation describes an attempt to increase the proportion of so-called “helper” lipids in LNP formulations containing mRNA. It is shown that high (40 mol%) levels of helper lipids such as egg sphingomyelin (ESM) can result in improved gene expression both in vitro and in vivo, particularly in extrahepatic tissues such as bone marrow. This ability is attributed to the unique morphology of these LNP systems which exhibit a “solid” hydrophobic core surrounded by a lipid bilayer. Such systems allow improved distribution to extrahepatic tissues due to an enhanced circulation lifetime.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chander, Nisha
Contributors dc:contributor
  • Cullis, Pieter

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/79276

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Chander, Nisha. Optimization of lipid nanoparticles containing small molecule drugs and genetic drugs. doctoral thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/79276